Compare VIR & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | LIND |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 899.2M |
| IPO Year | 2019 | 2011 |
| Metric | VIR | LIND |
|---|---|---|
| Price | $9.03 | $19.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $29.30 | $19.00 |
| AVG Volume (30 Days) | ★ 2.9M | 800.1K |
| Earning Date | 05-25-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | 5.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | $131.58 | $9.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $7.45 |
| 52 Week High | $10.91 | $21.23 |
| Indicator | VIR | LIND |
|---|---|---|
| Relative Strength Index (RSI) | 62.52 | 56.77 |
| Support Level | $4.88 | $11.58 |
| Resistance Level | N/A | $21.23 |
| Average True Range (ATR) | 0.58 | 0.81 |
| MACD | 0.16 | -0.18 |
| Stochastic Oscillator | 51.86 | 13.94 |
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.